27
Participants
Start Date
August 31, 2006
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Palifermin
Palifermin will be administered as an IV bolus injection (40, 60 or 80 µg/kg/day)once daily for 3 consecutive days before the start of conditioning regimen and after HCST (Day -10, -9, -8 and Day 0, +1, +2 respectively).
Total Body irradiation
Chemotherapy
High dose etoposide, Cyclophosphamide
Arizona Cancer Center, Tucson
Loma Linda University, Loma Linda
Children´s Hospital, Los Angeles
Regents of University of California, Los Angeles
Children´s Hospital of Orange, Orange
Children´s Memorial, Chicago
University of Texas, Dallas
Lead Sponsor
Swedish Orphan Biovitrum
INDUSTRY